Schedule 13G ownership disclosure

BRAINSTORM CELL THERAPEUTICS INC

Security class unavailable · CUSIP: 10501E102

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
762,547
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000041
Form type
SC 13G/A
Filer
BRAINSTORM CELL THERAPEUTICS INC.
CIK
CIK 1137883
Filed
Feb 02, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub